[go: up one dir, main page]

AU2002368326A1 - Hormone replacement therapy with drospirenone - Google Patents

Hormone replacement therapy with drospirenone

Info

Publication number
AU2002368326A1
AU2002368326A1 AU2002368326A AU2002368326A AU2002368326A1 AU 2002368326 A1 AU2002368326 A1 AU 2002368326A1 AU 2002368326 A AU2002368326 A AU 2002368326A AU 2002368326 A AU2002368326 A AU 2002368326A AU 2002368326 A1 AU2002368326 A1 AU 2002368326A1
Authority
AU
Australia
Prior art keywords
drospirenone
replacement therapy
hormone replacement
hormone
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368326A
Inventor
Siegfried Meyerhofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2002368326A1 publication Critical patent/AU2002368326A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002368326A 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone Abandoned AU2002368326A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/004628 WO2004041288A1 (en) 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone

Publications (1)

Publication Number Publication Date
AU2002368326A1 true AU2002368326A1 (en) 2004-06-07

Family

ID=32310068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368326A Abandoned AU2002368326A1 (en) 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone

Country Status (2)

Country Link
AU (1) AU2002368326A1 (en)
WO (1) WO2004041288A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005056527A1 (en) * 2005-11-25 2007-07-12 Grünenthal GmbH Use of a combination of ethinylestradiol and chlormadinone acetate for the manufacture of a medicament
WO2011128336A1 (en) 2010-04-15 2011-10-20 Bayer Pharma Aktiengesellschaft Very low-dosed solid oral dosage forms for hrt
DE102011012712A1 (en) * 2011-03-01 2012-09-06 Frank Lehmann-Horn Use of aldosterone receptor antagonists for the treatment of female sexual dysfunction
AU2016282863B2 (en) * 2015-06-23 2021-05-27 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083528A (en) * 1995-09-28 2000-07-04 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
UA74141C2 (en) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Oral pharmaceutical compositions comprising micronized eplerenone (variants), method for its production and method for treating aldosterone-mediated states (variants)
EP1354604A1 (en) * 1998-12-23 2003-10-22 G.D. Searle LLC. Combinations for cardiovascular indications
SI1611892T1 (en) * 2000-01-18 2010-01-29 Bayer Schering Pharma Ag Pharmaceutical compositions comprising drospirenone
JP2004518611A (en) * 2000-07-27 2004-06-24 ファルマシア・コーポレーション Aldosterone blocker therapy to prevent or treat inflammation-related disorders
ES2251505T3 (en) * 2000-08-28 2006-05-01 Pharmacia Corporation USE OF AN ALGOSTERONE RECEIVER ANTAGONIST TO IMPROVE COGNOSCITIVE FUNCTION.
DE10100911A1 (en) * 2001-01-11 2002-08-01 Schering Ag Process for hormone replacement therapy and its dosage form

Also Published As

Publication number Publication date
WO2004041288A1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
AU2003288586A1 (en) Electrode arrangement
AU2003288959A1 (en) Body region indication
EP1578782A3 (en) Combination therapy with co-stimulatory factors
AU2003202910A1 (en) Pivotable strap-buckle assembly
AU2003260760A1 (en) Implantable replacement joint
AU2003276447A1 (en) Inhalers
AU2003296895A1 (en) Combination therapy for controlling appetites
AU2003209226A1 (en) Adiponectin gene therapy
IL157944A0 (en) Hormone replacement therapy
AU2003259457A1 (en) Auto-destructible syringe
AU2003234929A1 (en) Therapeutic agent for diabetes
AU2003203099A1 (en) Manually-propelled wheelchair
AU2002313298A1 (en) Body reinforcing material arrangement structure
AU2003293253A1 (en) Selecting electrotherapy dosage
AU2003228198A1 (en) Av-fistula bandage
AU2003206730A1 (en) Fitting
AU2003215150A1 (en) Therapeutic compounds
AU2002368326A1 (en) Hormone replacement therapy with drospirenone
AU2003243360A1 (en) Polyamine-mediated transfection
AU2003257843A1 (en) Wheelchair
AU2003213956A1 (en) Improved hormone replacement therapy
AU2002952559A0 (en) New use
AU2003214499A1 (en) Allyl-phenol compounds in androgenic disorders
AU2003222541A1 (en) Homogeneous cathode unit
HK1060061A (en) Hormone replacement therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase